Inhibitory Activity of Coumarins from Artemisia capillaris against Advanced Glycation Endproduct Formation|RISS 상세보기

다국어 초록 (Multilingual Abstract)

Since glycation can lead to the onset of diabetic complications due to chronic hyperglycemia, several indigenous Artemisia species were evaluated as potential inhibitors of advanced glycation endproducts (AGE). Among them, the Artemisia capillaris plant demonstrated the highest AGE inhibitory activity. Repeated column chromatography was performed to isolate a new acylated flavonoid glycoside, acacetin-7-O-(6''-O-acetyl)-β-D-glucopyranosyl-(1→2)[α-L-rhamnopyranosyl]-(1→6)-β-D-glucopyranoside, along with 11 known flavonoids (acacetin-7-O-β-Dglucopyranosyl-(1→2)[α-L-rhamnopyranosyl]-(1→6)-β-D-glucopyranoside, linarin, quercetin, hyperoside, isorhamnetin, isorhamnetin 3-galactoside, isorhamnetin 3-glucoside, isorhamnetin 3-arabinoside, isorhamnetin 3-robinobioside, arcapillin, and cirsilineol), six coumarins (umbelliferone, esculetin, scopoletin, scopolin, isoscopolin, and scoparone), and two phenolic derivatives (4,5-di-O-caffeoylquinic acid and chlorogenic acid). In determining the structure-activity relationship (SAR), it was found that the presence and position of hydroxyl group of test coumarins (coumarin, esculin, isoscopoletin, daphnetin, 4-methylcoumarin, and six isolated coumarins) may play a crucial role in AGE inhibition. A free hydroxyl group at C-7 and a glucosyl group instead of a methoxyl group at C-6 are two important parameters for the inhibitory potential of coumarins on AGE formation. A. capillaris and five key AGE inhibitors, including 4,5-di-Ocaffeoylquinic acid, umbelliferone, esculetin, esculin, and scopoletin, were identified as potential candidates for use as therapeutic or preventive agents for diabetic complications and oxidative stress-related diseases. We understand this to be the first detailed study on the SAR of coumarins in AGE inhibition.

번역하기

참고문헌 (Reference)

1 서경순, "인진(茵蔯)으로 쓰이는 사철쑥과 더위지기 추출물의 항산화 활성" 한국자원식물학회 21 (21): 292-298, 2008

2 Li, H., "XLF-III-43, a novel coumarin−aspirin compound, prevents diabetic nephropathy in rats via inhibiting advanced glycation end products" 627 : 340-347, 2010

3 Altan, V. M., "The pharmacology of diabetic complications" 10 : 1317-1327, 2003

4 Yamahara, J., "The effect of scoparone, a coumarin derivative isolated from the Chinese crude drug Artemisiae capillaris flos, on the heart" 37 : 1297-1299, 1989

5 Hong, S. H., "The aqueous extract from Artemisia capillaris Thunb. inhibits lipopolysaccharide-induced inflammatory response through preventing NF-κB activation in human hepatoma cell line and rat liver" 13 : 717-720, 2004

6 Park, K. H., "The antioxidative and anti-inflammatory effects of caffeoyl derivatives from the roots of Aconitum koreanum R. RAYMOND" 32 : 2029-2033, 2009

7 여지영, "The anti-diabetic effects of ethanol extract from two variants of Artemisia princeps Pampanini in C57BL/KsJ-db/db mice" PERGAMON-ELSEVIER SCIENCE LTD 45 : 2022-2029, 200710

8 Matsuda, H., "Structural requirements of flavonoids for inhibition of protein glycation and radical scavenging activities" 11 : 5317-5323, 2003

9 Kordali, S., "Screening of chemical composition and antifungal and antioxidant activities of the essential oils from three Turkish Artemisia species" 53 : 1408-1416, 2005

10 Seon Il Jang, "Scoparone from Artemisia capillaris Inhibits the Release of Inflammatory Mediators in RAW 264.7 Cells upon Stimulation Cells by Interferon-γ Plus LPS" 대한약학회 28 (28): 203-208, 2005